Chronic inflammation of the salivary glands from pathologic conditions such as Sjögren’s syndrome can result in glandular destruction and hyposalivation. To understand which molecular factors may play a role in clinical cases of salivary gland hypofunction, we developed an aquaporin 5 (AQP5) Cre mouse line to produce genetic recombination predominantly within the acinar cells of the glands. We then bred these mice with the TNF-αglo transgenic line to develop a mouse model with salivary gland–specific overexpression of TNF-α; which replicates conditions seen in sialadenitis, an inflammation of the salivary glands resulting from infection or autoimmune disorders such as Sjögren’s syndrome. The resulting AQP5-Cre/TNF-αglo mice display severe inflammation in the salivary glands with acinar cell atrophy, fibrosis, and dilation of the ducts. AQP5 expression was reduced in the salivary glands, while tight junction integrity appeared to be disrupted. The immune dysregulation in the salivary gland of these mice led to hyposalivation and masticatory dysfunction.
AzumaMMotegiKAotaKHayashiYSatoM.1997. Role of cytokines in the destruction of acinar structure in Sjögren’s syndrome salivary glands. Lab Invest. 77(3):269–280.
2.
BakerOJCamdenJMRedmanRSJonesJESeyeCIErbLWeismanGA.2008. Proinflammatory cytokines tumor necrosis factor-alpha and interferon-gamma alter tight junction structure and function in the rat parotid gland Par-C10 cell line. Am J Physiol Cell Physiol. 295(5):C1191–C1201.
3.
BoumbaDSkopouliFNMoutsopoulosHM.1995. Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren’s syndrome. Br J Rheumatol. 34(4):326–333.
4.
DolanJCLamDKAchdjianSHSchmidtBL.2010. The dolognawmeter: a novel instrument and assay to quantify nociception in rodent models of orofacial pain. J Neurosci Methods. 187(2):207–215.
5.
EwertPAguileraSAlliendeCKwonYJAlbornozAMolinaCUrzúaUQuestAFOleaNPérezPet al. 2010. Disruption of tight junction structure in salivary glands from Sjögren’s syndrome patients is linked to proinflammatory cytokine exposure. Arthritis Rheum. 62(5):1280–1289.
6.
Fernandez-SolariJPrestifilippoJPOssolaCARettoriVElverdinJC.2010. Participation of the endocannabinoid system in lipopolysaccharide-induced inhibition of salivary secretion. Arch Oral Biol. 55(8):583–590.
7.
FlodbyPBorokZBanfalviAZhouBGaoDMinooPAnnDKMorriseyEECrandallED.2010. Directed expression of Cre in alveolar epithelial type 1 cells. Am J Respir Cell Mol Biol. 43(2):173–178.
8.
FoxRIKangHIAndoDAbramsJPisaE.1994. Cytokine mRNA expression in salivary gland biopsies of Sjögren’s syndrome. J Immunol. 152(11):5532–5539.
9.
GrisiusMMFoxPC.2003. Salivary gland diseases. In: Burkett’s oral medicine diagnosis and treatment. 10th ed.London (UK): BC Decker Inc. p. 235–265.
10.
HallBEZhangLSunZJUtrerasEProchazkovaMChoATerseAAranyPDolanJCSchmidtBLet al. 2016. Conditional TNF-α overexpression in the tooth and alveolar bone results in painful pulpitis and osteitis. J Dent Res. 95(2):188–195.
11.
HallBEZhengCSwaimWDChoANagineniCNEckhausMAFlandersKCAmbudkarISBaumBJKulkarniAB.2010. Conditional overexpression of TGF-beta1 disrupts mouse salivary gland development and function. Lab Invest. 90(4):543–555.
12.
HeXJShipJWuXZBrownAMWellnerRB.1989. Beta-adrenergic control of cell volume and chloride transport in an established rat submandibular cell line. J Cell Physiol. 138(3):527–535.
13.
IshimaruNHayashiY.2009. Regulation of T cell activation in Sjögren’s syndrome. Jpn Dent Sci Rev. 45(1):41–45.
14.
KangEHLeeYJHyonJYYunPYSongYW.2011. Salivary cytokine profiles in primary Sjögren’s syndrome differ from those in non-Sjögren sicca in terms of TNF-α levels and Th-1/Th-2 ratios. Clin Exp Rheumatol. 29(6):970–976.
15.
KoskiHJaninAHumphreys-BeherMGSorsaTMalmströmMKonttinenYT.2001. Tumor necrosis factor-alpha and receptors for it in labial salivary glands in Sjögren’s syndrome. Clin Exp Rheumatol. 19(2):131–137.
16.
LaiZYinHCabrera-PérezJGuimaroMCAfioneSMichaelDGGlentonPPatelASwaimWDZhengCet al. 2016. Aquaporin gene therapy corrects Sjögren’s syndrome phenotype in mice. Proc Natl Acad Sci U S A. 113(20):5694–5699.
17.
MarietteXRavaudPSteinfeldSBaronGGoetzJHachullaECombeBPuéchalXPennecYSauvezieBet al. 2004. Inefficacy of infliximab in primary Sjögren’s syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren’s Syndrome (TRIPSS). Arthritis Rheum. 50(4):1270–1276.
18.
MingWJBersaniLMantovaniA.1987. Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. J Immunol. 138(5):1469–1474.
19.
MoutsopoulosNMKatsifisGEAngelovNLeakanRASankarVPillemerSWahlSM.2008. Lack of efficacy of etanercept in Sjögren syndrome correlates with failed suppression of tumour necrosis factor alpha and systemic immune activation. Ann Rheum Dis. 67(10):1437–1443.
20.
MuzumdarMDTasicBMiyamichiKLiLLuoL.2007. A global double-fluorescent Cre reporter mouse. Genesis. 45(9):593–605.
21.
NandulaSRAmarnathSMolinoloABandyopadhyayBCHallBGoldsmithCMZhengCLarssonJSreenathTChenWet al. 2007. Female mice are more susceptible to developing inflammatory disorders due to impaired transforming growth factor beta signaling in salivary glands. Arthritis Rheum. 56(6):1798–1805.
22.
OxholmPDanielsTEBendtzenK.1992. Cytokine expression in labial salivary glands from patients with primary Sjögren’s syndrome. Autoimmunity. 12(3):185–191.
RozasPLazcanoPPiñaRChoAMadridRGonzalez-BillaultCKulkarniABUtrerasE.2015. Targeted overexpression of tumor necrosis factor-α (TNF-α) in nociceptive tissues increased cyclin-dependent kinase 5 (Cdk5) activity with subsequent increased of Ca+2 influx on trigeminal ganglia neurons. Pain. 157(6):1346–1362.
25.
SasakiYTsubotaKKawediaJDMenonAGYasuiM.2007. The difference of aquaporin 5 distribution in acinar and ductal cells in lacrimal and parotid glands. Curr Eye Res. 32(11):923–929.
26.
SeifertGDonathK.1976. Classification of the pathohistology of diseases of the salivary glands—review of 2,600 cases in the Salivary Gland Register. Beitr Pathol. 159(1):1–32.
27.
SistoMD’AmoreMCaprioSMitoloVScagliusiPLisiS.2009. Tumor necrosis factor inhibitors block apoptosis of human epithelial cells of the salivary glands. Ann N Y Acad Sci. 1171:407–414.
28.
SolivenBWangN.1995. Tumor necrosis factor-alpha regulates nicotinic responses in mixed cultures of sympathetic neurons and nonneuronal cells. J Neurochem. 64(2):883–894.
29.
SteinfeldSCoganEKingLSAgrePKissRDelporteC.2001. Abnormal distribution of aquaporin-5 water channel protein in salivary glands from Sjögren’s syndrome patients. Lab Invest. 81(2):143–148.
30.
SunZJZhangLHallBBianYGutkindJSKulkarniAB.2012. Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model. Clin Cancer Res. 18(19):5304–5313.
YamamuraYMotegiKKaniKTakanoHMomotaYAotaKYamanoiTAzumaM.2012. TNF-α inhibits aquaporin 5 expression in human salivary gland acinar cells via suppression of histone H4 acetylation. J Cell Mol Med. 16(8):1766–1775.
33.
YangYSHughesTE.2001. Cre stoplight: a red/green fluorescent reporter of Cre recombinase expression in living cells. Biotechniques. 31(5):1036, 1038, 1040–1041.
34.
ZhouBAnnDKFlodbyPMinooPLieblerJMCrandallEDBorokZ.2008. Rat aquaporin-5 4.3-kb 5′-flanking region differentially regulates expression in salivary gland and lung in vivo. Am J Physiol Cell Physiol. 295(1):C111–C120.
35.
ZhouJKawaiTYuQ.2017. Pathogenic role of endogenous TNF-α in the development of Sjögren’s-like sialadenitis and secretory dysfunction in non-obese diabetic mice. Lab Invest. 97(4):458–467.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
